<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05087472</url>
  </required_header>
  <id_info>
    <org_study_id>1</org_study_id>
    <nct_id>NCT05087472</nct_id>
  </id_info>
  <brief_title>Prevalence of Psychiatric Disorders in the Refugee Population of Turkey</brief_title>
  <official_title>Prevalence of Psychiatric Disorders in the Refugee Population of Turkey</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kutahya Health Sciences University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kutahya Health Sciences University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are planning to diagnose psychiatric disorders in willing participants from&#xD;
      the refugee population in Turkey.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Any diagnosed psychiatric disorder using the Mini-International Neuropsychiatric Interview</measure>
    <time_frame>Through study completion, on average five months</time_frame>
    <description>The Mini-International Neuropsychiatric Interview (M.I.N.I.) is a short structured diagnostic interview designed to screen for DSM-5 and ICD-10 psychiatric disorders. It will be utilized on willing participants from Turkey's refugee population.</description>
  </primary_outcome>
  <enrollment type="Anticipated">372</enrollment>
  <condition>Psychiatric Disorder</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Outpatients in a primary care clinic who have official refugee status&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Having official refugee status in Turkey, willing to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Having any disability that prevents answering interviewers' questions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Süleyman Keleş</last_name>
    <phone>+905063232982</phone>
    <email>slymnkeles@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kütahya Health Sciences University</name>
      <address>
        <city>Kütahya</city>
        <zip>43100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <contact>
      <last_name>Süleyman Keleş</last_name>
      <phone>+905063232982</phone>
      <email>slymnkeles@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 25, 2021</study_first_submitted>
  <study_first_submitted_qc>October 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 21, 2021</study_first_posted>
  <last_update_submitted>October 9, 2021</last_update_submitted>
  <last_update_submitted_qc>October 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kutahya Health Sciences University</investigator_affiliation>
    <investigator_full_name>Suleyman Keles, MD</investigator_full_name>
    <investigator_title>Psychiatrist, Head of Community Psychiatry Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Problem Behavior</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

